Skip to main content

Table 1 Patient demographics and clinical characteristics at diagnosis

From: Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution

Parameter

Data

Gender

 

 Male

10 (40%)

 Female

15 (60%)

Age (years)

 

 Median

54

 Range

15–78

Sokal score at diagnosis

 

 Low

10 (40%)

 Intermediate

10 (40%)

 High

5 (20%)